Log in

Relevant bibliographies by topics / Therapeutics / Journal articles

To see the other types of publications on this topic, follow the link: Therapeutics.

Journal articles on the topic 'Therapeutics'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Therapeutics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sakshi, Bodke Mayuri Jagtap* Avinash Darekar. "RNA Therapeutics: Clinical Pharmacokinetic and Therapeutic Monitoring." International Journal of Scientific Research and Technology 1, no. 3 (2024): 25–30. https://doi.org/10.5281/zenodo.13884776.

Full text

Abstract:

Drug development for the treatment of disease is being revolutionised by RNA-based oligonucleotide therapies. This class of drugs differs from small molecule and protein therapies in several ways, such as how they work and how they are related to clinical pharmacology. Since the COVID-19 mRNA vaccine was approved and nucleoside base alterations won the Nobel Prize in 2023, RNA treatments have gained attention and are revolutionising the drug development process. Although the phrase "RNA therapeutics" has been applied in several settings, the focus of this review is on therapies that target RNA

APA, Harvard, Vancouver, ISO, and other styles

2

Pandey, Khushboo. "Homoeopathic Therapeutics of Migraine." International Journal of Science and Research (IJSR) 10, no. 1 (2021): 427–29. https://doi.org/10.21275/sr21107123743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Misselbrook, David. "Therapeutics?" British Journal of General Practice 71, no. 713 (2021): 553. http://dx.doi.org/10.3399/bjgp21x717845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Azimi, A., S. Kuznecovs, J. Kuznecovs, et al. "Therapeutics." Annals of Oncology 23, suppl 5 (2012): v23—v32. http://dx.doi.org/10.1093/annonc/mds162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Joyce, David A., and Kenneth F. Ilett. "Therapeutics." Medical Journal of Australia 161, no. 10 (1994): 622–26. http://dx.doi.org/10.5694/j.1326-5377.1994.tb127645.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Zipursky, Robert. "THERAPEUTICS." Schizophrenia Research 153 (April 2014): S65. http://dx.doi.org/10.1016/s0920-9964(14)70209-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Van Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (2018): i. http://dx.doi.org/10.1016/s1094-9194(18)30020-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

van Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (2018): xiii—xv. http://dx.doi.org/10.1016/j.cvex.2018.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Alisi, Anna, Sara Tomaselli, Clara Balsano, and Angela Gallo. "Hepatitis C virus therapeutics: Editing enzymes promising therapeutic targets?" Hepatology 54, no. 2 (2011): 742. http://dx.doi.org/10.1002/hep.24409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Srivastava, Shobhit Prakash, Vishal Rai, Amrita Shukla, Adarsh Trivedi, Yash Gupta, and Soban Khan. "The Rise of RNA-Based Therapeutics: Recent Advances and Therapeutic Potential." Journal for Research in Applied Sciences and Biotechnology 2, no. 6 (2024): 216–26. http://dx.doi.org/10.55544/jrasb.2.6.31.

Full text

Abstract:

In recent years, RNA-based therapeutics have emerged as a groundbreaking field, offering innovative approaches for drug development and therapeutic interventions. This review article presents a comprehensive exploration of the advancements in RNA-based therapeutics, focusing on key modalities such as RNA interference (RNAi), antisense oligonucleotides (ASOs), messenger RNA (mRNA) vaccines, and other emerging RNA-based therapies. The introduction provides an insightful overview of the potential of RNA as a therapeutic target, highlighting its unique mechanisms of action and its transformative r

APA, Harvard, Vancouver, ISO, and other styles

11

Yoo, Joo Hun, Harim Jeong, and Tai-Myoung Chung. "Cutting-Edge Technologies for Digital Therapeutics: A Review and Architecture Proposals for Future Directions." Applied Sciences 13, no. 12 (2023): 6929. http://dx.doi.org/10.3390/app13126929.

Full text

Abstract:

Digital therapeutics, evidence-based treatments delivered through software programs, are revolutionizing healthcare by utilizing cutting-edge computing technologies. Unlike conventional medical treatment methods, digital therapeutics are based on multiple information technologies, from data collection to analysis algorithms, and treatment support approaches. In this research, we provide a comprehensive overview of the latest technologies involved in the development of digital therapeutics and highlight specific technologies necessary for the future growth of the rapidly evolving digital therap

APA, Harvard, Vancouver, ISO, and other styles

12

Barish, Robert A., and Jerome F. X. Naradzay. "Ophthalmologic Therapeutics." Emergency Medicine Clinics of North America 13, no. 3 (1995): 649–67. http://dx.doi.org/10.1016/s0733-8627(20)30611-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Greish, Khaled, Jun Fang, Takao Inutsuka, Akinori Nagamitsu, and Hiroshi Maeda. "Macromolecular Therapeutics." Clinical Pharmacokinetics 42, no. 13 (2003): 1089–105. http://dx.doi.org/10.2165/00003088-200342130-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Katsarou, Angeliki, and Kostas Pantopoulos. "Hepcidin Therapeutics." Pharmaceuticals 11, no. 4 (2018): 127. http://dx.doi.org/10.3390/ph11040127.

Full text

Abstract:

Hepcidin is a key hormonal regulator of systemic iron homeostasis and its expression is induced by iron or inflammatory stimuli. Genetic defects in iron signaling to hepcidin lead to “hepcidinopathies” ranging from hereditary hemochromatosis to iron-refractory iron deficiency anemia, which are disorders caused by hepcidin deficiency or excess, respectively. Moreover, dysregulation of hepcidin is a pathogenic cofactor in iron-loading anemias with ineffective erythropoiesis and in anemia of inflammation. Experiments with preclinical animal models provided evidence that restoration of appropriate

APA, Harvard, Vancouver, ISO, and other styles

15

Cheng, Juei-Tang, I.-Min Liu, and Szu-Chuan Shen. "Plant Therapeutics." Plants 11, no. 20 (2022): 2720. http://dx.doi.org/10.3390/plants11202720.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Yang, Priscilla L. "Antiviral Therapeutics." ACS Infectious Diseases 7, no. 6 (2021): 1297. http://dx.doi.org/10.1021/acsinfecdis.1c00271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Shafer, Steven L., and Richard Simoneaux. "Omicron Therapeutics." ASA Monitor 86, no. 2 (2022): 21–37. http://dx.doi.org/10.1097/01.asm.0000820396.70292.ef.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tong, Rong, David A. Christian, Li Tang, et al. "Nanopolymeric Therapeutics." MRS Bulletin 34, no. 6 (2009): 422–31. http://dx.doi.org/10.1557/mrs2009.118.

Full text

Abstract:

AbstractPolymers have been extensively utilized in the design of nanometer-sized delivery vehicles of chemotherapeutics for clinical cancer therapy. Polymeric nanoparticulate delivery vehicles, with chemotherapeutics being either conjugated or encapsulated, have been developed into a variety of different architectures, including polymer-drug conjugates with linear or branched polymers, micelles, and polymersomes. This review describes the progress that has been made in the field of polymeric nanomedicine that brings the science closer to clinical realization of nanopolymeric therapeutics for i

APA, Harvard, Vancouver, ISO, and other styles

19

Ritter, J. M. "Experimental Therapeutics." British Journal of Clinical Pharmacology 57, no. 3 (2004): 354. http://dx.doi.org/10.1111/j.1365-2125.2003.02031.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Fletcher, Liz. "Mojave Therapeutics." Nature Biotechnology 20, S6 (2002): BE16. http://dx.doi.org/10.1038/nbt0602supp-be16a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

van Brunt, Jennifer. "AIDS Therapeutics." Nature Biotechnology 6, no. 7 (1988): 767–70. http://dx.doi.org/10.1038/nbt0788-767.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Napper, Dr Genevieve, Dr Julie Albietz, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 85, no. 6 (2002): 397–98. http://dx.doi.org/10.1111/j.1444-0938.2002.tb02393.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Napper, Genevieve, Julie Albietz, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 86, no. 1 (2003): 63–64. http://dx.doi.org/10.1111/j.1444-0938.2003.tb03060.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Albietz, Dr Julie, and Ian Douglas. "Ocular therapeutics." Clinical and Experimental Optometry 86, no. 2 (2003): 131–32. http://dx.doi.org/10.1111/j.1444-0938.2003.tb03072.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Napper, Dr Genevieve, Ian Douglas, and Dr Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 87, no. 1 (2004): 42–43. http://dx.doi.org/10.1111/j.1444-0938.2004.tb03146.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 6 (2005): 428–29. http://dx.doi.org/10.1111/j.1444-0938.2005.tb05112.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 1 (2005): 60–61. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06667.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 2 (2005): 119–20. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06681.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 3 (2005): 188–89. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06694.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 4 (2005): 259–60. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06706.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 88, no. 5 (2005): 354–55. http://dx.doi.org/10.1111/j.1444-0938.2005.tb06721.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 1 (2006): 45–46. http://dx.doi.org/10.1111/j.1444-0938.2006.00011.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 3 (2006): 188–89. http://dx.doi.org/10.1111/j.1444-0938.2006.00035.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 4 (2006): 261–62. http://dx.doi.org/10.1111/j.1444-0938.2006.00053.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 5 (2006): 334–35. http://dx.doi.org/10.1111/j.1444-0938.2006.00078.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 89, no. 6 (2006): 396–97. http://dx.doi.org/10.1111/j.1444-0938.2006.00095.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 1 (2007): 57–58. http://dx.doi.org/10.1111/j.1444-0938.2007.00118.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 2 (2007): 141–42. http://dx.doi.org/10.1111/j.1444-0938.2007.00126.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Napper, Genevieve, Ian Douglas, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 3 (2007): 212–13. http://dx.doi.org/10.1111/j.1444-0938.2007.00144.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 4 (2007): 303. http://dx.doi.org/10.1111/j.1444-0938.2007.00165.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Albietz, Julie, Ian Douglas, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 5 (2007): 386–87. http://dx.doi.org/10.1111/j.1444-0938.2007.00182.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 90, no. 6 (2007): 474. http://dx.doi.org/10.1111/j.1444-0938.2007.00200.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 1 (2008): 120–21. http://dx.doi.org/10.1111/j.1444-0938.2007.00238.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 2 (2008): 193–94. http://dx.doi.org/10.1111/j.1444-0938.2008.00251.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 3 (2008): 322–23. http://dx.doi.org/10.1111/j.1444-0938.2008.00266.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Albietz, Julie, and Genevieve Napper. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 5 (2008): 480–81. http://dx.doi.org/10.1111/j.1444-0938.2008.00317.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Napper, Genevieve, and Julie Albietz. "Ocular therapeutics." Clinical and Experimental Optometry 91, no. 6 (2008): 565. http://dx.doi.org/10.1111/j.1444-0938.2008.00329.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Marks, Steven L., and Joseph Taboada. "Transdermal Therapeutics." Journal of the American Animal Hospital Association 39, no. 1 (2003): 19–21. http://dx.doi.org/10.5326/0390019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bentley, Stephen, and Mohammed Sebaihia. "Bacterial therapeutics." Nature Reviews Microbiology 5, no. 3 (2007): 170–71. http://dx.doi.org/10.1038/nrmicro1633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Pattison, Richard. "Thermal therapeutics." Nature Methods 14, no. 1 (2017): 13. http://dx.doi.org/10.1038/nmeth.4139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!